Device Trial Radar · NCT04025710
Master Study of the BIOMONITOR III and Incision and Insertion Tool (FIT OneStep)
Last checked: Nov 21, 2026Latest source record: Nov 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
167
Actual
Start
Oct 17, 2019
Primary completion
Jun 30, 2021
Study completion Apr 6, 2022
Sponsor
- Lead sponsor
- Biotronik SE & Co. KGNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 19, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a post-market clinical follow-up (PMCF) study to identify and evaluate residual risks associated with the use of the BIOMONITOR III and BIOMONITOR IIIm that are discovered or remain even after risk analysis, risk mitigation and successful conformity assessment. Furthermore, this study will also provide additional data as required by regulatory authorities outside of the CE-region.
Conditions
- Tachyarrhythmia
- Atrial Fibrillation (AF)
- Syncope
- Cryptogenic Stroke
Interventions
BIOMONITOR III and BIOMONITOR IIImDevice
* Insertion of BIOMONITOR III or BIOMONITOR IIIm * three scheduled in-office follow-ups * 48-hour Holter ECG
Primary outcomes
What the sponsor says the trial is designed to measure.
- SADE-free Rate Until the 3-month Follow-upTime frame: 3 months
Locations
27 sites in 6 countries. Site status is shown where the registry gives one.
GenesisCare Wesley
Auchenflower, Australia
26 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.